
Joseph R. Pokrzywa
Examiner (ID: 4325, Phone: (571)272-7410 , Office: P/3992 )
| Most Active Art Unit | 3992 |
| Art Unit(s) | 2625, 2622, 2722, 3992 |
| Total Applications | 418 |
| Issued Applications | 257 |
| Pending Applications | 104 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14531659
[patent_doc_number] => 20190201450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => Method for Treating Multiple Sclerosis
[patent_app_type] => utility
[patent_app_number] => 16/353127
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353127
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353127 | Method for treating multiple sclerosis | Mar 13, 2019 | Issued |
Array
(
[id] => 14535125
[patent_doc_number] => 20190203184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 16/294223
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16294223
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/294223 | OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM | Mar 5, 2019 | Abandoned |
Array
(
[id] => 14497233
[patent_doc_number] => 20190192271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => CELL-CONTAINING SHEET
[patent_app_type] => utility
[patent_app_number] => 16/288790
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16288790
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/288790 | CELL-CONTAINING SHEET | Feb 27, 2019 | Abandoned |
Array
(
[id] => 16569113
[patent_doc_number] => 20210008119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => ALLOGENEIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/969558
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969558
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969558 | ALLOGENEIC COMPOSITION | Feb 14, 2019 | Abandoned |
Array
(
[id] => 14407463
[patent_doc_number] => 20190169575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/273076
[patent_app_country] => US
[patent_app_date] => 2019-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16273076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/273076 | SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | Feb 10, 2019 | Abandoned |
Array
(
[id] => 14407453
[patent_doc_number] => 20190169570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => METHOD FOR MANUFACTURING CILIARY MARGINAL ZONE-LIKE STRUCTURE
[patent_app_type] => utility
[patent_app_number] => 16/267948
[patent_app_country] => US
[patent_app_date] => 2019-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16267948
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/267948 | Method for manufacturing ciliary marginal zone-like structure | Feb 4, 2019 | Issued |
Array
(
[id] => 14403769
[patent_doc_number] => 20190167728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs
[patent_app_type] => utility
[patent_app_number] => 16/263060
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16263060
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/263060 | In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs | Jan 30, 2019 | Abandoned |
Array
(
[id] => 16619161
[patent_doc_number] => 20210037814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => DEVICE AND METHOD FOR FREEZE DRYING BIOLOGICAL SAMPLES
[patent_app_type] => utility
[patent_app_number] => 16/963974
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963974
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963974 | DEVICE AND METHOD FOR FREEZE DRYING BIOLOGICAL SAMPLES | Jan 10, 2019 | Abandoned |
Array
(
[id] => 18886385
[patent_doc_number] => 11865141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Composition for improving, preventing or treating skin disease comprising induced pluripotency stem cell-derived mesenchymal stem cells pretreated with interferon gamma and exosomes derived therefrom
[patent_app_type] => utility
[patent_app_number] => 16/959366
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 7233
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959366
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959366 | Composition for improving, preventing or treating skin disease comprising induced pluripotency stem cell-derived mesenchymal stem cells pretreated with interferon gamma and exosomes derived therefrom | Jan 6, 2019 | Issued |
Array
(
[id] => 14277821
[patent_doc_number] => 20190136195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/237399
[patent_app_country] => US
[patent_app_date] => 2018-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16237399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/237399 | COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF | Dec 30, 2018 | Abandoned |
Array
(
[id] => 16451018
[patent_doc_number] => 20200360444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => CELL POPULATION INCLUDING ADHESIVE STEM CELLS, PRODUCTION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/958117
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958117 | CELL POPULATION INCLUDING ADHESIVE STEM CELLS, PRODUCTION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION | Dec 27, 2018 | Abandoned |
Array
(
[id] => 15711563
[patent_doc_number] => 20200102547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => REPROSOMES, AS EXOSOMES CAPABLE OF INDUCING REPROGRAMMING OF CELLS AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/230242
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16230242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/230242 | REPROSOMES, AS EXOSOMES CAPABLE OF INDUCING REPROGRAMMING OF CELLS AND PREPARATION METHOD THEREOF | Dec 20, 2018 | Abandoned |
Array
(
[id] => 14581799
[patent_doc_number] => 20190218508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => METHODS OF CELL SEPARATION
[patent_app_type] => utility
[patent_app_number] => 16/226544
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16226544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/226544 | METHODS OF CELL SEPARATION | Dec 18, 2018 | Abandoned |
Array
(
[id] => 14468517
[patent_doc_number] => 20190185901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => SAMPLE PROCESSING METHOD AND SAMPLE CULTURING METHOD
[patent_app_type] => utility
[patent_app_number] => 16/222862
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/222862 | Sample processing method and sample culturing method | Dec 16, 2018 | Issued |
Array
(
[id] => 16939903
[patent_doc_number] => 11052118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Enhanced stem cell composition
[patent_app_type] => utility
[patent_app_number] => 16/218314
[patent_app_country] => US
[patent_app_date] => 2018-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 30867
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16218314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/218314 | Enhanced stem cell composition | Dec 11, 2018 | Issued |
Array
(
[id] => 16948389
[patent_doc_number] => 20210207080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => SERUM-FREE MEDIA FORMULATION FOR CULTURING CELLS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/770052
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -99
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770052 | SERUM-FREE MEDIA FORMULATION FOR CULTURING CELLS AND METHODS OF USE THEREOF | Dec 6, 2018 | Pending |
Array
(
[id] => 16312621
[patent_doc_number] => 20200291359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => ECTODERMAL MESENCHYMAL STEM CELLS AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/768203
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768203
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768203 | Ectodermal mesenchymal stem cells and method for producing same | Nov 29, 2018 | Issued |
Array
(
[id] => 16932734
[patent_doc_number] => 20210198623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => MACROCARRIER
[patent_app_type] => utility
[patent_app_number] => 16/761825
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761825 | MACROCARRIER | Nov 8, 2018 | Abandoned |
Array
(
[id] => 13955563
[patent_doc_number] => 20190054125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/178240
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178240
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/178240 | hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS | Oct 31, 2018 | Abandoned |
Array
(
[id] => 14990899
[patent_doc_number] => 20190314407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => COMPOSITIONS AND METHODS FOR THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/177252
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16177252
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/177252 | COMPOSITIONS AND METHODS FOR THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS | Oct 30, 2018 | Abandoned |